Accusations can go back and forth, opinions on Malcolm will always differ between the RBW's and the "anti-CYGX" group. Whether CYGX paid for publications is a matter of which way you look at it. But the company's financial situation is the only real issue that needs resolution at this point. If they run out of money then the game is over. Period. We'll see the latest 10-Q in due course for the quarter that ended on September 30th. We'll see if they booked any meaningful synDNA revenue. We'll see how much money they raised in PPO sales and at what price. We'll see how much money they have left in their bank account. Because without money they can't finish the facility, they can't pay rent on their current facility, they can't pay salaries, they can't pay their FICA taxes, and they can't pay their lawyers. Malcolm already declines to cash his own paychecks because he realizes how desperate the financial picture is. Whatever the merits of the CYGX science and whatever the future prospects might be for synDNA, it is undeniable that the company must last long enough to prosper. To do so they need cash. If the cash runs out all the other questions regarding the company, its history and its management will be moot.
